ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Diverging targets mediate the pathological role of miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis

Zeng, Ni; Huang, Yu-Qing; Yan, Yu-Min; Hu, Zhi-Qin; Zhang, Zhuo; Feng, Jia-Xin; Guo, Ji-Shen; Zhu, Jie-Ning; Fu, Yong-Heng; Wang, Xi-Pei; Zhang, Meng-Zhen; Duan, Jin-Zhu; Zheng, Xi-Long; Xu, Jin-Dong*; Shan, Zhi-Xin*广东省人民医院; 广东省心血管病研究所; 广州医学院; 南方医科大学; 1
Molecular Therapy-Nucleic Acids2021-12-3DOI: 10.1016/j.omtn.2021.10.013
15被引6阅读
引用收藏
分享

摘要

MicroRNA-199a-5p (miR-199a-5p) and -3p are enriched in the myocardium, but it is unknown whether miR-199a-5p and -3p are co-expressed in cardiac remodeling and what roles they have in cardiac hypertrophy and fibrosis. We show that miR-199a-5p and -3p are co-upregulated in the mouse and human myocardium with cardiac remodeling and in Ang-II-treated neonatal mouse ventricular cardiomyocytes (NMVCs) and cardiac fibroblasts (CFs). miR-199a-5p and -3p could aggravate cardiac hypertrophy and fibrosis in vivo and in vitro. PPAR gamma coactivator 1 alpha (Ppargc1a) and sirtuin 1 (Sirt1) were identified as target genes to mediate miR-199a-5p in promoting both cardiac hypertrophy and fibrosis. However, miR-199a-3p aggravated cardiac hypertrophy and fibrosis through targeting RB transcriptional corepressor 1 (Rb1) and Smad1, respectively. Serum response factor and nuclear factor kappa B p65 participated in the upregulation of miR-199a-5p and -3p in Ang-II-treated NMVCs and mouse CFs, and could be conversely elevated by miR-199a-5p and -3p. Together, Ppargc1a and Sirt1, Rb1 and Smad1 mediated the pathological effect of miR-199a-5p and -3p by promoting cardiac hypertrophy and fibrosis, respectively. This study suggests a possible new strategy for cardiac remodeling therapy by inhibiting miR-199a-5p and -3p.

学科与关键词

关键词
MICRORNA EXPRESSIONCELL-CYCLECARDIOMYOCYTESTRESSDEREPRESSESATTENUATIONDYSFUNCTIONACTIVATION
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Molecular Therapy-Nucleic Acids
发表日期
2021-12-03
卷期
第 26 卷
页码
1035-1050
DOI
10.1016/j.omtn.2021.10.013
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Science Foundation of China [82070254, 81770264, 81470439]; Guangzhou Science and Technology Program Project [202002030013, 202002030039, 202102080093]; High-level Hospital Construction Project of Guangdong Provincial People's Hospital [DFJH201902]

作者

  • Z

    Zeng, Ni (第一作者)

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • H

    Huang, Yu-Qing

查看全部 15 位作者收起作者
  • Y

    Yan, Yu-Min

    southern med univ

  • H

    Hu, Zhi-Qin

    southern med univ

  • Z

    Zhang, Zhuo

  • F

    Feng, Jia-Xin

  • G

    Guo, Ji-Shen

    2 · southern med univ

  • Z

    Zhu, Jie-Ning

    guangdong cardiovasc inst

  • F

    Fu, Yong-Heng

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • W

    Wang, Xi-Pei

    guangdong prov peoples hosp

  • Z

    Zhang, Meng-Zhen

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • D

    Duan, Jin-Zhu

    guangzhou med univ · guangzhou women & childrens med ctr

  • Z

    Zheng, Xi-Long

    1 · 2

  • X

    Xu, Jin-Dong (通讯)

    guangdong prov peoples hosp

  • S

    Shan, Zhi-Xin (通讯)

    guangdong cardiovasc inst · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417